Delivery Order 36F79721D0141-36C24526N0177
Award Date 12/5/25
Potential Completion Date 12/9/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Recordati Rare Diseases Inc. received a firm fixed-price delivery order award of $33.7K from the Department of Veterans Affairs' Veterans Integrated Service Network 5 for Signifor LAR 20 and 40 mg pharmaceutical products. The award was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and will be performed in Bartlett, Tennessee. This delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation and...
- The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract worth $10,811.24 to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group. The contract is for the supply of Signifor LAR 40 MG, a treatment for Cushing's disease and acromegaly. This award is associated with Recordati's larger, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, as well as a $3.1 million Blanket Purchase Agreement (BPA) for a range of...
- This is a federal contract award to Recordati Rare Diseases Inc., a division of the Recordati Group, an international pharmaceutical company. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is for the delivery of SIGNIFOR LAR 40 MG, which is used to treat Cushing's disease and acromegaly. The contract has a ceiling value of $10,811.24 and is a firm fixed-price delivery order under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. The contract does...
- The Department of Veterans Affairs Veterans Health Administration awarded a $21,623.35 firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a foreign-owned, for-profit manufacturer of specialty pharmaceutical products. The contract is for the supply of SIGNIFOR LAR 30 MG AND 40 MG, which treats rare conditions such as Cushing's disease and acromegaly. This delivery order was placed against Recordati's existing Federal Supply Schedule (FSS-61-IB) contract for...
- Recordati Rare Diseases Inc. was awarded a $21,622.48 firm fixed price delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The delivery order has a completion date of February 27, 2024 and was issued on February 23, 2024. Recordati holds two key indefinite-delivery vehicles for supplying pharmaceuticals to VA, including a...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in rare disease treatments. The contract, valued at $11,219.21, is for the supply of Signifor LAR 40 MG, a medication used to treat Cushing's disease. The delivery order was placed under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, which allows the VA to efficiently...
- This federal contract award is for the supply of Signifor LAR 40 mg, a pharmaceutical product used to treat Cushing's disease and acromegaly. The contract was awarded to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer that specializes in rare disease treatments. The contract is a delivery order placed against Recordati's Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs (VA), a $15.6 million multiple-award schedule for...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $22,438.42 contract is for the drug SIGNIFOR LAR 40 MG and is part of the company's broader Federal Supply Schedule (FSS-61-IB) contract with the VA, valued at $15.6 million, as well as a $3,156,115 Blanket Purchase Agreement covering multiple rare disease treatments. The award has no set-aside...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor, Recordati Rare Diseases Inc. Division, will deliver the pharmaceutical to a facility in Bartlett, Tennessee to support VHA's Veterans Integrated Service Network 5. The firm fixed price order runs from October 20th through the 24th of 2023. The contract utilizes...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor, Recordati Rare Diseases Inc. Division, will deliver the pharmaceutical to the VA Veterans Integrated Service Network 5 location in Bartlett, Tennessee between December 7-11, 2023. The firm fixed price order is funded by the VA-VHA to support its provision of...